Annual report pursuant to Section 13 and 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.24.1
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 10, 2023
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Revenue, net   $ 17,417 $ 16,410
Gross profit   6,556 7,217
Non-cash share based compensation   (818) (2,343)
Depreciation and amortization   (981) (1,241)
Intangible asset impairment   0 19,000
Loss from operations   (15,594) (46,919)
Loss on debt extinguishment, net   0 2,263
Gain on remeasurement of warrant liability $ (6) (113) (2,092)
Loss (Gain) on investments   3,738 (6,851)
Foreign exchange loss   433 963
Interest expense   46 2,672
Other expense (income), net   31 220
Loss before income taxes and equity investment loss   (19,729) (44,094)
Operating Segments      
Segment Reporting Information [Line Items]      
Revenue, net   17,417 16,410
Gross profit   (8,536) (16,008)
Operating Segments | Cannabinoid      
Segment Reporting Information [Line Items]      
Revenue, net   6,558 4,729
Gross profit   (10,783) (17,354)
Operating Segments | Non-Cannabinoid      
Segment Reporting Information [Line Items]      
Revenue, net   10,859 11,681
Gross profit   2,247 1,346
Other      
Segment Reporting Information [Line Items]      
Unallocated corporate expenses   (7,221) (8,328)
Non-cash share based compensation   (818) (2,343)
Depreciation and amortization   981 (1,240)
Intangible asset impairment   0 19,000
Loss from operations   $ (15,594) $ (46,919)